Cell therapy uses viable healthy cells to replace, expand, and/or enhance a population of cells in order to achieve a therapeutic effect against a disease. The cell therapy field is rapidly…
Clarivate Epidemiology’s coverage of anaplastic lymphoma kinase- (ALK)-mutated cancers comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (…
Clarivate Epidemiology’s coverage of acute coronary syndrome (ACS) comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and…
Amgen, Q3 2019 Amgen Earnings Conference Call Presentation. Accessed on October 31, 2019.Baselga J, et al. Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. NEJM. Jan 12;366(…
AbbVie has rigorously defended the IP surrounding its multibillion-dollar product Humira in the United States, resulting in a favorable outcome that is set to prevent biosimilar entry for several…
Biosimilar sponsors are not required to replicate all reference product clinical trials for the approval of their biosimilars via regulatory agencies’ abbreviated pathways. However, they need to…
The development and commercialization of biosimilars require significant investment in capital, resources, and time. Biosimilars developers must ensure that they are equipped with the necessary…